Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Sign in
Join now
Eric Jonasch MD
Eric Jonasch MD Advisory Board
Rafael Fonseca MD
Rafael Fonseca MD Editor-in-Chief
Lee Schwartzberg MD, FACP
Lee S. Schwartzberg MD, FACP Advisory Board
See All Experts
featured
Published in Oncology

Journal Scan / Research · July 28, 2016

Chemotherapy-Induced Neutropenia Predicts Survival in Refractory Metastatic CRC

BMC Cancer

 

 Save  Recommend
 Share

Additional Info

Disclosure statements are available on the authors' profiles:

Axel Grothey MD

BMC Cancer
Chemotherapy Induced Neutropenia at 1-Month Mark Is a Predictor of Overall Survival in Patients Receiving TAS-102 for Refractory Metastatic Colorectal Cancer: A Cohort Study
BMC Cancer 2016 Jul 01;16(xx)467, PM Kasi, D Kotani, M Cecchini, K Shitara, A Ohtsu, RK Ramanathan, HS Hochster, A Grothey, T Yoshino

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading

Most Read This Week

Recently Updated